Literature DB >> 17099293

Localized expression of histamine H1 receptors in syncytiotrophoblast cells of human placenta.

Kazuto Matsuyama1, Tatsuya Ichikawa, Yuichi Nitta, Yoshio Ikoma, Kazutaka Ishimura, Shuhei Horio, Hiroyuki Fukui.   

Abstract

The previous Northern blot analysis and in situ hybridization studies showed that histamine H1-receptor (H1R) mRNA is expressed in human placenta and suggested that H(1)R plays some roles in the function of placenta in pregnancy. To investigate further, it is essential to show the precise location of H1R in the placenta. In the present study, we investigated H1R expression in human placenta by radioligand binding assay and immunohistochemical study using an antibody against human H1R. Placentas were obtained from normal uncomplicated deliveries. Membranes prepared from the tissue exhibited saturable [3H]mepyramine binding (K(d) = 4.0 +/- 0.6 nM and B(max) = 91.4 +/- 4.9 fmol/mg of protein). Stereoisomers of chlorpheniramine inhibited [(3)H]mepyramine binding; d-chlorpheniramine inhibited more potently than l-chlorpheniramine, K(i) values being 1.1 +/- 0.4 and 270 +/- 170 nM, respectively. The placenta tissues were positively immunostained with anti-H1R antibody only in the region of the syncytiotrophoblast of chorionic villus. The tissues were double stained with anti-H1R antibody and an antibody against human chorionic gonadotoropin (hCG) that is solely expressed in placental syncytiotrophoblast cells. The results showed that H1R and hCG were expressed on the same cells, that is, syncytiotrophoblast cells. These results indicate that H1Rs are specifically expressed in syncytiotrophoblast cells of human placenta organ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099293     DOI: 10.1254/jphs.fp0060862

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  3 in total

Review 1.  The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.

Authors:  Fatma Etwel; Lauren H Faught; Michael J Rieder; Gideon Koren
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

2.  First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth.

Authors:  Tiara D Aldridge; Katherine E Hartmann; Kara A Michels; Digna R Velez Edwards
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-05-01       Impact factor: 2.890

3.  Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies.

Authors:  Huberdina P M Smedts; Linda de Jonge; Sarah J G Bandola; Marlies E Baardman; Marian K Bakker; Bruno H C Stricker; Régine P M Steegers-Theunissen
Journal:  Eur J Epidemiol       Date:  2014-06-20       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.